Works matching IS 00278874 AND DT 2025 AND VI 117 AND IP 3
Results: 31
RE: Characteristics of a cost-effective blood test for colorectal cancer screening.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2025, v. 117, n. 3, p. 570, doi. 10.1093/jnci/djae340
- By:
- Publication type:
- Article
Response to Lehrer and Rheinstein and to Alexiou, Zagorianakou, and Voulgaris.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2025, v. 117, n. 3, p. 568, doi. 10.1093/jnci/djae345
- By:
- Publication type:
- Article
Re: Association of immunoglobulin E levels with glioma risk and survival.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2025, v. 117, n. 3, p. 567, doi. 10.1093/jnci/djae344
- By:
- Publication type:
- Article
Re: Association of immunoglobulin E levels with glioma risk and survival.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2025, v. 117, n. 3, p. 565, doi. 10.1093/jnci/djae343
- By:
- Publication type:
- Article
Response to Hu, Yang, and Sun.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2025, v. 117, n. 3, p. 572, doi. 10.1093/jnci/djae341
- By:
- Publication type:
- Article
Correction to: Drug and biomarker tissue levels in a randomized presurgical trial on exemestane alternative schedules.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2025, v. 117, n. 3, p. 574, doi. 10.1093/jnci/djaf018
- Publication type:
- Article
Response to Liu and Zhang.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2025, v. 117, n. 3, p. 564, doi. 10.1093/jnci/djae325
- By:
- Publication type:
- Article
RE: Glucagon-like peptide 1 receptor agonists and pancreatic cancer risk: target trial emulation using real-world data.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2025, v. 117, n. 3, p. 562, doi. 10.1093/jnci/djae324
- By:
- Publication type:
- Article
Stat Bite: Convergence of long-term trends in cervix uteri cancer incidence among Black and White women from 1975 to 2021.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2025, v. 117, n. 3, p. 575, doi. 10.1093/jnci/djae316
- By:
- Publication type:
- Article
Testing stored control-arm specimens could dramatically increase statistical power yet reduce costs in cancer screening trials.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2025, v. 117, n. 3, p. 393, doi. 10.1093/jnci/djae293
- By:
- Publication type:
- Article
Reducing—a little—the high price of randomized trials of the efficacy of multicancer early detection.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2025, v. 117, n. 3, p. 391, doi. 10.1093/jnci/djae292
- By:
- Publication type:
- Article
The widespread application of trans-oral robotic surgery in HPV-related head and neck cancer: one size does not fit all.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2025, v. 117, n. 3, p. 388, doi. 10.1093/jnci/djae291
- By:
- Publication type:
- Article
Validation of a breast cancer assay for radiotherapy omission: an individual participant data meta-analysis.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2025, v. 117, n. 3, p. 486, doi. 10.1093/jnci/djae262
- By:
- Publication type:
- Article
Risk of type 2 diabetes after breast cancer treatment: a population-based cohort study in Denmark.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2025, v. 117, n. 3, p. 537, doi. 10.1093/jnci/djae261
- By:
- Publication type:
- Article
Glucagon-like peptide-1 receptor agonists and pancreatic cancer risk: target trial emulation using real-world data.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2025, v. 117, n. 3, p. 476, doi. 10.1093/jnci/djae260
- By:
- Publication type:
- Article
Cancer chemotherapy in pregnancy and adverse pediatric outcomes: a population-based cohort study.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2025, v. 117, n. 3, p. 554, doi. 10.1093/jnci/djae273
- By:
- Publication type:
- Article
Association of immunoglobulin E levels with glioma risk and survival.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2025, v. 117, n. 3, p. 545, doi. 10.1093/jnci/djae265
- By:
- Publication type:
- Article
Life after cancer matters: supporting 2.1 million survivors of adolescent and young adult cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2025, v. 117, n. 3, p. 385, doi. 10.1093/jnci/djae284
- By:
- Publication type:
- Article
Adjuvant modified FOLFIRINOX for resected pancreatic adenocarcinoma: clinical insights and genomic features from a large contemporary cohort.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2025, v. 117, n. 3, p. 496, doi. 10.1093/jnci/djae269
- By:
- Publication type:
- Article
Novel metabolomic predictors of incident colorectal cancer in men and women.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2025, v. 117, n. 3, p. 517, doi. 10.1093/jnci/djae270
- By:
- Publication type:
- Article
Reducing learning and psychosocial disparities in Latino children with cancer: a randomized intervention trial.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2025, v. 117, n. 3, p. 465, doi. 10.1093/jnci/djae256
- By:
- Publication type:
- Article
Polygenic risk scores stratify breast cancer risk among women with benign breast disease.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2025, v. 117, n. 3, p. 456, doi. 10.1093/jnci/djae255
- By:
- Publication type:
- Article
Risk factors for second primary breast cancer by laterality, age, and race and ethnicity.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2025, v. 117, n. 3, p. 436, doi. 10.1093/jnci/djae254
- By:
- Publication type:
- Article
More efficient, smaller multicancer screening trials.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2025, v. 117, n. 3, p. 450, doi. 10.1093/jnci/djae251
- By:
- Publication type:
- Article
Prevalence of cancer survivors diagnosed during adolescence and young adulthood in the United States.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2025, v. 117, n. 3, p. 529, doi. 10.1093/jnci/djae250
- By:
- Publication type:
- Article
Disparities in the availability of and access to neuro-oncology trial-supporting infrastructure in the United States.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2025, v. 117, n. 3, p. 511, doi. 10.1093/jnci/djae240
- By:
- Publication type:
- Article
Streamlining the conduct of cancer clinical trials: new standard data collection practices for National Cancer Institute late-phase clinical studies.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2025, v. 117, n. 3, p. 396, doi. 10.1093/jnci/djae239
- By:
- Publication type:
- Article
Gerotherapeutics: aging mechanism–based pharmaceutical and behavioral interventions to reduce cancer racial and ethnic disparities.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2025, v. 117, n. 3, p. 406, doi. 10.1093/jnci/djae211
- By:
- Publication type:
- Article
Lower survival for surgical treatment of human papillomavirus–related oropharynx cancer at community cancer centers.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2025, v. 117, n. 3, p. 423, doi. 10.1093/jnci/djae220
- By:
- Publication type:
- Article
When is prostate cancer really cancer?
- Published in:
- JNCI: Journal of the National Cancer Institute, 2025, v. 117, n. 3, p. 402, doi. 10.1093/jnci/djae200
- By:
- Publication type:
- Article
Impact of COVID-19 on 2021 cancer incidence rates and potential rebound from 2020 decline.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2025, v. 117, n. 3, p. 507, doi. 10.1093/jnci/djae180
- By:
- Publication type:
- Article